Healthcare Analytical Testing Services Market

Report Code AST 4341
Published in Apr, 2024, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Healthcare Analytical Testing Services Market Size by Type (Biomarker Testing, Stability Testing, Raw Material Testing, Batch-release Testing, Cleaning Validation), End User (Pharmaceutical Companies, Medical Device Companies) & Region - Global Forecast to 2029

Overview

The global size of healthcare analytical testing services market in terms of revenue was estimated to be worth $7.4 billion in 2024 and is poised to reach $12.6 billion by 2029, growing at a CAGR of 11.2% from 2024 to 2029. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. This notable growth driven by various factors. The growing market for healthcare analytical testing services is driven by various factors. There is a rising demand across industries for services ensuring quality assurance and regulatory compliance. Additionally, the pursuit of precise analytical techniques presents opportunities for service providers, while governmental initiatives support investment and innovation. These efforts collectively contribute to the global expansion of the market. Moreover, outsourcing strategies driven by cost-effectiveness and the evolving pharmaceutical landscape further stimulate market growth. Additionally, expanding into new markets amplifies the need for tailored testing solutions, thereby increasing demand for healthcare analytical testing services. The evolving regulatory landscape, the imperative to avoid impractical investments, and the necessity to minimize the risk of product recalls are significant drivers for the Healthcare analytical testing services market.

Attractive Opportunities in the Healthcare Analytical Testing Services Market

North America

North America is expected to be the largest regional market for Analytical testing services owing to the presence of major pharmaceutical and biotechnology companies and increasing investments in technological advancements in this region.

The analytical testing services market is expected to grow due to stringent regulatory requirements, rise in biologic and biosimilar testing and increased clinical trials.

The North American analytical testing services market is expected to be worth USD 12.63 billion by 2029, growing at a CAGR of 11.22% during the forecast period.

Product launches, collaboration, acquisitions, and partnerships are expected to offer lucrative opportunities for market players in the next five years.

Europe is the second largest market for analytical testing services owing to the direct indirect financial investment, increasing healthcare expenditure and increasing research activity and academia industry partnership in this region

Global Healthcare Analytical Testing Services Market Dynamics

Driver: Changing regulatory landscape and the increasing complexity of products to drive the market

The growth of the market in healthcare is propelled by changing regulatory mandates and the increasing complexity of healthcare products. Regulatory agencies enforce stringent standards for pharmaceuticals, medical devices, and other healthcare products, necessitating comprehensive testing to ensure compliance. Additionally, advancements in medical technology have led to the development of complex drugs, biologics, and medical devices, requiring sophisticated analytical techniques for characterization and quality assurance. These factors drive the demand for healthcare analytical testing services in the healthcare industry, contributing to market growth.Rising number of Clinical TrialsThe rise in clinical trials is a significant driver behind the growth of the market. As pharmaceutical, biopharmaceutical, and medical device companies continue to innovate and develop new products, the demand for healthcare analytical testing services surges. Clinical trials are crucial stages in the development and approval process of new drugs and medical devices. These trials require rigorous testing to ensure safety, efficacy, and regulatory compliance. Healthcare analytical testing services play a pivotal role in conducting various tests, including bioanalytical, pharmacokinetic, and biomarker testing, among others. The increasing number of clinical trials globally, fueled by advancements in medical research and the quest for novel treatments, directly translates to a higher demand for healthcare analytical testing services. Moreover, the complexity of clinical trial designs and the stringent regulatory requirements further accentuate the need for specialized testing capabilities, driving the growth of the market.

Restraint: Lack of skilled professionals

The lack of skilled professionals poses a significant challenge that could hamper market growth for market. As demand for testing services continues to rise across various industries, including pharmaceuticals, food and beverage, and environmental testing, there is a growing need for trained personnel proficient in operating Analytical testing equipment and interpreting analytical results accurately. However, the shortage of skilled professionals in this field can hinder the growth of the market, leading to delays in research and development activities, quality control processes, and regulatory compliance efforts. Addressing this skills gap through training programs, educational initiatives, and talent development strategies will be essential to overcome this obstacle and sustain market growth for market.

 

Opportunity: Harnessing Government Support and Technology Advancements in Healthcare analytical testing services

Supportive government initiatives, coupled with the increasing adaptability to Software as a Service (SaaS) and outcome-based software technology, present significant opportunities for the market in healthcare. Government funding programs, tax incentives, and regulatory reforms aimed at improving healthcare infrastructure and research capabilities drive investment in healthcare analytical testing services, ensuring compliance and quality control. The adoption of SaaS models enables smaller laboratories and healthcare facilities to access advanced analytical capabilities cost-effectively, enhancing efficiency and data management practices. Additionally, outcome-based software technology delivers measurable results and value by providing predictive analytics and customized recommendations, optimizing decision-making processes. Collectively, these trends empower healthcare organizations to leverage sophisticated analytical tools, streamline workflows, and deliver better outcomes for patients and stakeholders, driving the growth of the market.

Challenge: Need for improvement to the sensitivity of analytical testing

The need for improvement in sensitivity of bioanalytical methods poses a significant challenge for the pharmaceutical industry. With the development of new chemical entities (NCEs) that are increasingly potent and effective, there is growing pressure to detect drug substances and their metabolites with greater sensitivity. This demand is further compounded by the exploration of unconventional chemical classes for highly potent therapeutics. Bioanalytical scientists are tasked with supporting early-stage in vivo work by generating high-quality data within shorter timeframes. However, meeting the sensitivity requirements for new and challenging compounds administered at very low levels can be daunting. It often necessitates extensive sample preparation, such as solid-phase or liquid-liquid extraction, as well as complex chromatography techniques like two-dimensional or trap-and-elute liquid chromatography. While automation can streamline the time required for these processes, the development of appropriate methods remains time-consuming, especially given the tight timelines typically faced by bioanalytical departments.

Global Healthcare Analytical Testing Services Market Ecosystem Analysis

Healthcare Analytical Testing Services Market Segmentation & Geographical Spread The Healthcare analytical testing services Market ecosystem comprises entities responsible for the end-to-end workflow of analytical testing types and services. The major stakeholders present in this market include Analytical testing service providers, pharmaceutical, biopharmaceutical, and biotechnology companies, food and beverage industry, environment protection and forensic institutes, clinicians, researchers, hospitals, and clinics, and medical device companies. The service providers in the industry continue to enhance and mature their offerings to add value.

 

The Healthcare analytical testing services industry, is projected to grow at a CAGR of 11.2% between 2024 and 2029.”

The Healthcare analytical testing services market is projected to reach USD 12.6 billion by 2029 from USD 7.4 billion in 2023, at a CAGR of 11.2% during the forecast period. The rising preference to outsource testing, stringent regulatory requirements, increase in clinical trials and rising R & D investments are driving the growth of this market.

Biohealthcare analytical testing services segment accounted for a substantial share of the Healthcare analytical testing services industry, by type in 2023.”

The dominance of the biohealthcare analytical testing services segment in the healthcare analytical testing services market stems from its comprehensive range of services tailored to various drug types, such as vaccines, small molecules, and biologics. These services play a crucial role in ensuring the safety, efficacy, and quality of pharmaceutical products. By offering extensive bioanalytical testing solutions, including assays for drug quantification, metabolite identification, and pharmacokinetic analysis, this segment meets the diverse needs of pharmaceutical companies across the drug development process. Additionally, advancements in analytical techniques and technologies have enabled the segment to enhance its capabilities, further solidifying its position as a key player in the market.

North America region holds the largest share of the Healthcare Analytical Testing Services Market.

Prominent players in the Healthcare analytical testing services market include The prominent players in the global market include Eurofins Scientific (Luxembourg), Laboratory Corporation of America Holdings (US), SGS S.A. (Switzerland), Charles River Laboratories (US), WuXi AppTec Co. Ltd. (China), Element Materials Technology (UK), Thermo Fisher Scientific, Inc. (US), Pace Analytical Services LLC (US), Intertek Group plc (UK), IQVIA Inc. (US), Merck KGaA (Germany), Source BioScience (UK), Almac Group (UK), ICON Plc (Ireland), Frontage Laboratories, Inc. (US), STERIS Plc (US), Sartorius AG (Germany), ALS Life Science (US), Syneos Health, INC (US), Medpace Holdings, Inc. (US), LGC Limited (UK), Parexel International Corporation (US), Celerion (US). Pharmaron (China), and BioAgilytix Labs (US).

 
 

Recent Developments of Healthcare Analytical Testing Services Market industry

  • In March 2024, Thermo Fisher Scientific Inc. (US), collaborated with Symphogen (US), to provide biopharmaceutical discovery and development laboratories with innovative tools and streamlined workflows for efficient characterization of complex therapeutic proteins
  • In February 2024, Charles River Laboratories (US) partnered with Wheeler Bio, Inc. (US). This agreement accelerates the transition from preclinical to early clinical stages for biotech firms, streamlining processes and providing a comprehensive solutions.

Key Market Players

KEY PLAYERS IN THE Healthcare Analytical Testing Services Market INCLUDE

Want to explore hidden markets that can drive new revenue in Healthcare Analytical Testing Services Market?

Scope of the Report

Report Attribute Details
Market Revenue in 2024 $7.4 billion
Projected Revenue by 2029 $12.6 billion
Revenue Rate Poised to Grow at a CAGR of 11.2%
Market Driver Changing regulatory landscape and the increasing complexity of products to drive the market
Market Opportunity Harnessing Government Support and Technology Advancements in Healthcare analytical testing services

Key Questions Addressed by the Report

What is the projected market revenue value of the global healthcare analytical testing services market?
The global healthcare analytical testing services market boasts a total revenue value of $12.6 billion by 2029.
What is the estimated growth rate (CAGR) of the global healthcare analytical testing services market?
The global healthcare analytical testing services market has an estimated compound annual growth rate (CAGR) of 11.2% and a revenue size of approximately $7.4 billion in 2024.

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Healthcare Analytical Testing Services Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
34
RESEARCH METHODOLOGY
40
EXECUTIVE SUMMARY
54
PREMIUM INSIGHTS
59
MARKET OVERVIEW
64
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Stringent regulatory guidelines
    - Growing focus on analytical testing of biologics & biosimilars
    - Increasing outsourcing of analytical testing by pharmaceutical & medical device companies
    - Increasing number of clinical trials
    - Growing R&D expenditure in pharmaceutical & biopharmaceutical industry
    - Rising acceptance of quality-by-design approach in pharmaceutical research & manufacturing
    RESTRAINTS
    - Increasing pressure on market players due to rising costs and market competition
    OPPORTUNITIES
    - Adoption of new techniques and technologies
    - Growing focus on emerging economies
    CHALLENGES
    - Shortage of skilled professionals
    - Specific requirements for innovative formulations and medical devices
    - Need to improve sensitivity of bioanalytical methods
  • 5.3 ECOSYSTEM ANALYSIS
  • 5.4 VALUE CHAIN ANALYSIS
  • 5.5 CASE STUDY ANALYSIS
    UNLOCKING BIOPHARMACEUTICAL DEVELOPMENT POTENTIAL THROUGH OUTSOURCING ANALYTICAL TESTING
    REVOLUTIONIZING PHARMACEUTICAL TESTING: A CASE STUDY IN ANALYTICAL TESTING EVOLUTION
  • 5.6 PORTER’S FIVE FORCES ANALYSIS
    THREAT OF NEW ENTRANTS
    BARGAINING POWER OF SUPPLIERS
    INTENSITY OF COMPETITIVE RIVALRY
    BARGAINING POWER OF BUYERS
    THREAT OF SUBSTITUTES
  • 5.7 REGULATORY LANDSCAPE
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    REGULATORY ANALYSIS
    NORTH AMERICA
    EUROPE
    ASIA PACIFIC
  • 5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
  • 5.9 KEY CONFERENCES & EVENTS, 2024–2025
  • 5.10 INVESTMENT AND FUNDING SCENARIO
  • 5.11 KEY STAKEHOLDERS & BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    BUYING CRITERIA
HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE
90
  • 6.1 INTRODUCTION
  • 6.2 BIOANALYTICAL TESTING
    PHARMACOKINETIC & TOXICOKINETIC TESTING
    - Increasing number of clinical trials for drug development to propel growth
    IMMUNOGENICITY & NEUTRALIZING ANTIBODY TESTING
    - Increasing requirement for drug safety approvals to support market growth
    BIOMARKER TESTING
    - Rising need for specialized drug development to drive market
    BIOASSAY TESTING
    - Growing adoption of high-content screening for cytotoxicity testing to fuel growth
    OTHER BIOANALYTICAL TESTING SERVICES
  • 6.3 PHYSICAL CHARACTERIZATION
    LASER PARTICLE SIZE ANALYSIS
    - Growing importance of particle size analysis in manufacturing pharmaceutical dosage forms to drive market
    THERMAL ANALYSIS
    - Advancements in thermal analysis techniques to support growth
    OPTICAL CHARACTERIZATION
    - Growing complexity of biological structures to contribute to growth
    SURFACE AREA ANALYSIS
    - Growing need for surface analysis to streamline drug development processes to fuel growth
    OTHER PHYSICAL CHARACTERIZATION SERVICES
  • 6.4 METHOD DEVELOPMENT & VALIDATION
    EXTRACTABLES/LEACHABLES METHOD DEVELOPMENT & VALIDATION
    - Growing development of parenterally administered drugs and biologic products to drive market
    PROCESS IMPURITY METHOD DEVELOPMENT & VALIDATION
    - Rising emphasis on impurity testing to boost market
    STABILITY-INDICATING METHOD VALIDATION
    - Need to ensure safety and efficacy of therapeutic drugs to spur growth
    CLEANING VALIDATION & METHOD DEVELOPMENT
    - Growing needs to evaluate cleaning practices and ensure complete decontamination to fuel growth
    ANALYTICAL STANDARD CHARACTERIZATION
    - Growing importance of analytical standard characterization in drug development to support market
    TECHNICAL CONSULTING
    - Need for regulatory approvals for drug development to drive market
    OTHER METHOD DEVELOPMENT & VALIDATION SERVICES
  • 6.5 RAW MATERIAL TESTING
    COMPLETE COMPENDIAL TESTING
    - Need to determine efficacy and safety of therapeutic products to drive growth
    CONTAINER TESTING
    - Need to optimize sealing and evaluate temperature impact to fuel growth
    HEAVY METAL TESTING
    - Implementation of various techniques and technologies for heavy metal testing to aid growth
    WATER CONTENT ANALYSIS
    - Need to check for water content in pharmaceutical products to support growth
    OTHER RAW MATERIAL TESTING SERVICES
  • 6.6 BATCH-RELEASE TESTING SERVICES
    DISSOLUTION TESTING
    - Wide usage of dissolution testing in formulation development and manufacturing to drive growth
    ELEMENTAL IMPURITY TESTING
    - Need to minimize cost of in-house analysis and labor to fuel growth
    DISINTEGRATION TESTING
    - Need to ensure batch-to-batch consistency of pharmaceutical dosage forms to promote growth
    HARDNESS TESTING
    - Need to assess manufacturability and compactness of pharmaceutical formulations to ensure growth
    FRIABILITY TESTING
    - Need to measure resistance of tablets and granules to abrasion or fracture to support market
    OTHER BATCH-RELEASE TESTING SERVICES
  • 6.7 STABILITY TESTING
    DRUG SUBSTANCE STABILITY TESTING
    - Regulatory requirements for drug approval to drive market
    FORMULATION EVALUATION STABILITY TESTING
    - Need to analyze and predict shelf life of products to drive demand
    ACCELERATED STABILITY TESTING
    - Growing use of accelerated stability testing to determine shelf life of pharmaceutical products to fuel growth
    PHOTOSTABILITY TESTING
    - Need for robust photostability testing process to ensure product quality and safety to drive adoption
    FORCED DEGRADATION TESTING
    - Regulatory requirements and need for comprehensive stability testing in pharmaceutical industry to boost market
    OTHER STABILITY TESTING SERVICES
  • 6.8 MICROBIAL TESTING
    MICROBIAL LIMIT TESTING
    - Need to determine whether products comply with compendial specifications for microbial quality to boost adoption
    VIROLOGY TESTING
    - Increasing outbreaks of viral diseases to drive market
    STERILITY TESTING
    - Rising development of parenteral preparations and immunological products to drive market
    ENDOTOXIN TESTING
    - Need to standardize procedures and follow regulatory guidelines to support demand
    PRESERVATIVE EFFICACY TESTING
    - Need to ensure product safety for product approval to support growth
    OTHER MICROBIAL TESTING SERVICES
  • 6.9 GENOMIC TESTING SERVICES
    NEED TO GAIN INSIGHTS INTO DISEASE MECHANISMS AND TREATMENT RESPONSES TO BOOST MARKET
  • 6.10 OTHER ANALYTICAL TESTING SERVICES
HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER
141
  • 7.1 INTRODUCTION
  • 7.2 PHARMACEUTICAL COMPANIES
    INCREASED OUTSOURCING OF R&D ACTIVITIES TO DRIVE MARKET GROWTH
  • 7.3 BIOPHARMACEUTICAL COMPANIES
    GROWING INVESTMENTS IN BIOPHARMACEUTICAL COMPANIES TO BOOST MARKET GROWTH
  • 7.4 MEDICAL DEVICE COMPANIES
    STRICT APPROVAL NORMS FOR MEDICAL DEVICES TO SUPPORT GROWTH
  • 7.5 HOSPITALS & CLINICS
    GROWING PREVALENCE OF CHRONIC DISEASES TO FAVOR MARKET GROWTH
  • 7.6 FORENSIC LABS
    GROWING USE OF ANALYTICAL TESTING IN FORENSIC LABS TO BOOST MARKET GROWTH
  • 7.7 COSMETIC & NUTRACEUTICAL COMPANIES
    STRINGENT GUIDELINES FOR QUALITY CONTROL TO DRIVE MARKET
HEALTHCARE ANALYTICAL TESTING MARKET, BY REGION
150
  • 8.1 INTRODUCTION
  • 8.2 NORTH AMERICA
    NORTH AMERICA: RECESSION IMPACT
    US
    - High number of pre-registration drugs in pipeline to drive market
    CANADA
    - Presence of well-established CROs to support market growth
  • 8.3 EUROPE
    EUROPE: RECESSION IMPACT
    GERMANY
    - Government support and flexible labor laws make Germany favorable location for clinical trials
    FRANCE
    - Favorable government regulations to drive market
    UK
    - Investments by pharmaceutical sponsors for drug discovery services to support growth
    ITALY
    - Low drug approval time to support market growth
    SWITZERLAND
    - Large and growing pharma production volume to drive demand for analytical testing services
    SPAIN
    - Rising R&D expenditure to boost growth
    REST OF EUROPE
  • 8.4 ASIA PACIFIC
    ASIA PACIFIC: RECESSION IMPACT
    CHINA
    - Low manufacturing cost of medicines to drive demand
    JAPAN
    - Rising geriatric population to support market growth
    INDIA
    - Increasing number of clinical trials to drive market
    AUSTRALIA
    - Large number of research institutes make Australia favorable location for drug discovery
    SOUTH KOREA
    - Growth in clinical trial activities to propel market
    REST OF ASIA PACIFIC
  • 8.5 LATIN AMERICA
    LATIN AMERICA: RECESSION IMPACT
    BRAZIL
    - Rising adoption of emerging medical technologies to drive market
    MEXICO
    - Government initiatives and robust supply to drive market
    REST OF LATIN AMERICA
  • 8.6 MIDDLE EAST & AFRICA
    MIDDLE EAST & AFRICA: RECESSION IMPACT
    GCC
    - Supportive government initiatives to aid market growth
    REST OF MIDDLE EAST & AFRICA
COMPETITIVE LANDSCAPE
279
  • 9.1 INTRODUCTION
  • 9.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS
  • 9.3 REVENUE SHARE ANALYSIS
  • 9.4 MARKET SHARE ANALYSIS
  • 9.5 COMPANY EVALUATION MATRIX: KEY PLAYERS
    STARS
    PERVASIVE PLAYERS
    EMERGING LEADERS
    PARTICIPANTS
    COMPANY FOOTPRINT
    - Overall footprint
    - Service footprint
    - End-user footprint
    - Regional footprint
  • 9.6 COMPANY EVALUATION MATRIX: START-UPS/SMES
    PROGRESSIVE COMPANIES
    DYNAMIC COMPANIES
    RESPONSIVE COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING
  • 9.7 VALUATION AND FINANCIAL METRICS OF HEALTHCARE ANALYTICAL TESTING SERVICE VENDORS
  • 9.8 BRAND/PRODUCT COMPARATIVE ANALYSIS
    EUROFINS SCIENTIFIC
    WUXI APPTEC
    CHARLES RIVER LABORATORIES
    SGS S.A.
    LABORATORY CORPORATION OF AMERICA HOLDINGS
  • 9.9 COMPETITIVE SCENARIO
    SERVICE LAUNCHES
    DEALS
COMPANY PROFILES
302
  • 10.1 KEY PLAYERS
    EUROFINS SCIENTIFIC
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    - MnM view
    LABORATORY CORPORATION OF AMERICA HOLDINGS
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    - MnM view
    WUXI APPTEC
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    - MnM view
    CHARLES RIVER LABORATORIES
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    - MnM view
    SGS S.A.
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    - MnM view
    THERMO FISHER SCIENTIFIC INC.
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    MEDPACE, INC.
    - Business overview
    - Products/Services/Solutions offered
    SARTORIUS AG
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    INTERTEK GROUP PLC
    - Business overview
    - Products/Services/Solutions offered.
    - Recent developments
    MERCK KGAA
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    SOURCE BIOSCIENCE
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    ICON PLC
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    ALS
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    FRONTAGE LABORATORIES, INC.
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    STERIS
    - Business overview
    - Products/Services/Solutions offered
    IQVIA INC.
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    ELEMENT MATERIALS TECHNOLOGY
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    PACE ANALYTICAL SERVICES
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    ALMAC GROUP
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    PHARMARON
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
  • 10.2 OTHER PLAYERS
    SYNEOS HEALTH
    PAREXEL INTERNATIONAL (MA) CORPORATION
    LGC LIMITED
    CELERION
    BIOAGILYTIX
APPENDIX
384
  • 11.1 DISCUSSION GUIDE
  • 11.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 11.3 CUSTOMIZATION OPTIONS
  • 11.4 RELATED REPORTS
  • 11.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 RISK ASSESSMENT ANALYSIS
  • TABLE 2 PATENT EXPIRY OF BEST-SELLING BIOLOGICS
  • TABLE 3 IMPACT ANALYSIS: DRIVERS
  • TABLE 4 IMPACT ANALYSIS: RESTRAINTS
  • TABLE 5 IMPACT ANALYSIS: OPPORTUNITIES
  • TABLE 6 IMPACT ANALYSIS: CHALLENGES
  • TABLE 7 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: ROLE IN ECOSYSTEM
  • TABLE 8 PORTER’S FIVE FORCES ANALYSIS
  • TABLE 9 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 10 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 11 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 12 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 13 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 14 ICH QUALITY GUIDELINES FOR PHARMACEUTICAL GMPS
  • TABLE 15 OVERVIEW OF GUIDELINES OF LABORATORY SERVICES
  • TABLE 16 DEVELOPMENT OF GLP ACROSS COUNTRIES
  • TABLE 17 REGULATORY AUTHORITIES AND LAUNCH OF GLP MONITORING PROGRAMS IN EUROPEAN COUNTRIES
  • TABLE 18 HEALTHCARE ANALYTICAL TESTING MARKET: DETAILED LIST OF CONFERENCES & EVENTS
  • TABLE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS
  • TABLE 20 KEY BUYING CRITERIA FOR END USERS
  • TABLE 21 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 22 BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 23 BIOANALYTICAL TESTING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 24 PHARMACOKINETIC TESTING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 25 IMMUNOGENICITY & NEUTRALIZING ANTIBODY TESTING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 26 BIOMARKER TESTING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 27 BIOASSAY TESTING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 28 OTHER BIOANALYTICAL TESTING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 29 PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 30 PHYSICAL CHARACTERIZATION SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 31 LASER PARTICLE SIZE ANALYSIS SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 32 THERMAL ANALYSIS SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 33 OPTICAL CHARACTERIZATION SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 34 SURFACE AREA ANALYSIS SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 35 OTHER PHYSICAL CHARACTERIZATION SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 36 METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 37 METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 38 EXTRACTABLES/LEACHABLES METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 39 PROCESS IMPURITY METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 40 STABILITY-INDICATING METHOD VALIDATION SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 41 CLEANING VALIDATION & METHOD DEVELOPMENT SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 42 ANALYTICAL STANDARD CHARACTERIZATION SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 43 TECHNICAL CONSULTING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 44 OTHER METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 45 RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 46 RAW MATERIAL TESTING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 47 COMPLETE COMPENDIAL TESTING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 48 CONTAINER TESTING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 49 HEAVY METAL TESTING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 50 WATER CONTENT ANALYSIS SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 51 OTHER RAW MATERIAL TESTING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 52 BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 53 BATCH-RELEASE TESTING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 54 DISSOLUTION TESTING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 55 ELEMENTAL IMPURITY TESTING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 56 BREAKDOWN OF DISINTEGRATION METHODS AND IMMERSION MEDIA
  • TABLE 57 DISINTEGRATION TESTING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 58 HARDNESS TESTING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 59 FRIABILITY TESTING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 60 OTHER BATCH-RELEASE TESTING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 61 STABILITY TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 62 STABILITY TESTING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 63 DRUG SUBSTANCE STABILITY TESTING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 64 FORMULATION EVALUATION STABILITY TESTING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 65 ACCELERATED STABILITY TESTING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 66 PHOTOSTABILITY TESTING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 67 FORCED DEGRADATION TESTING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 68 OTHER STABILITY TESTING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 69 MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 70 MICROBIAL TESTING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 71 STANDARD LIMITS FOR MICROBIAL LIMIT TESTING
  • TABLE 72 MICROBIAL LIMIT TESTING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 73 VIROLOGY TESTING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 74 STERILITY TESTING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 75 ENDOTOXIN TESTING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 76 PRESERVATIVE EFFICACY TESTING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 77 OTHER MICROBIAL TESTING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 78 GENOMIC TESTING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 79 OTHER ANALYTICAL TESTING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 80 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 81 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET FOR PHARMACEUTICAL COMPANIES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 82 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET FOR BIOPHARMACEUTICAL COMPANIES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 83 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET FOR MEDICAL DEVICE COMPANIES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 84 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET FOR HOSPITALS & CLINICS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 85 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET FOR FORENSIC LABS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 86 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET FOR COSMETIC & NUTRACEUTICAL COMPANIES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 87 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 88 NORTH AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 89 NORTH AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 90 NORTH AMERICA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 91 NORTH AMERICA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 92 NORTH AMERICA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 93 NORTH AMERICA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 94 NORTH AMERICA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 95 NORTH AMERICA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 96 NORTH AMERICA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 97 NORTH AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 98 US: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 99 US: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 100 US: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 101 US: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 102 US: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 103 US: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 104 US: STABILITY TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 105 US: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 106 CANADA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 107 CANADA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 108 CANADA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 109 CANADA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 110 CANADA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 111 CANADA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 112 CANADA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 113 CANADA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 114 EUROPE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 115 EUROPE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 116 EUROPE: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 117 EUROPE: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 118 EUROPE: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 119 EUROPE: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 120 EUROPE: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 121 EUROPE: STABILITY TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 122 EUROPE: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 123 EUROPE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 124 GERMANY: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 125 GERMANY: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 126 GERMANY: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 127 GERMANY: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 128 GERMANY: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 129 GERMANY: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 130 GERMANY: STABILITY TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 131 GERMANY: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 132 FRANCE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 133 FRANCE: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 134 FRANCE: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 135 FRANCE: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 136 FRANCE: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 137 FRANCE: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 138 FRANCE: STABILITY TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 139 FRANCE: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 140 UK: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 141 UK: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 142 UK: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 143 UK: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 144 UK: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 145 UK: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 146 UK: STABILITY TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 147 UK: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 148 ITALY: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 149 ITALY: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 150 ITALY: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 151 ITALY: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 152 ITALY: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 153 ITALY: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 154 ITALY: STABILITY TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 155 ITALY: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 156 SWITZERLAND: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 157 SWITZERLAND: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 158 SWITZERLAND: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 159 SWITZERLAND: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 160 SWITZERLAND: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 161 SWITZERLAND: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 162 SWITZERLAND: STABILITY TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 163 SWITZERLAND: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 164 SPAIN: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 165 SPAIN: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 166 SPAIN: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 167 SPAIN: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 168 SPAIN: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 169 SPAIN: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 170 SPAIN: STABILITY TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 171 SPAIN: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 172 REST OF EUROPE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 173 REST OF EUROPE: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 174 REST OF EUROPE: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 175 REST OF EUROPE: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 176 REST OF EUROPE: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 177 REST OF EUROPE: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 178 REST OF EUROPE: STABILITY TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 179 REST OF EUROPE: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 180 ASIA PACIFIC: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 181 ASIA PACIFIC: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 182 ASIA PACIFIC: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 183 ASIA PACIFIC: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 184 ASIA PACIFIC: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 185 ASIA PACIFIC: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 186 ASIA PACIFIC: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 187 ASIA PACIFIC: STABILITY TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 188 ASIA PACIFIC: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 189 ASIA PACIFIC: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 190 CHINA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 191 CHINA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 192 CHINA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 193 CHINA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 194 CHINA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 195 CHINA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 196 CHINA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 197 CHINA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 198 JAPAN: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 199 JAPAN: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 200 JAPAN: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 201 JAPAN: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 202 JAPAN: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 203 JAPAN: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 204 JAPAN: STABILITY TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 205 JAPAN: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 206 INDIA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 207 INDIA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 208 INDIA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 209 INDIA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 210 INDIA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 211 INDIA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 212 INDIA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 213 INDIA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 214 AUSTRALIA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 215 AUSTRALIA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 216 AUSTRALIA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 217 AUSTRALIA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 218 AUSTRALIA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 219 AUSTRALIA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 220 AUSTRALIA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 221 AUSTRALIA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 222 SOUTH KOREA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 223 SOUTH KOREA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 224 SOUTH KOREA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 225 SOUTH KOREA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 226 SOUTH KOREA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 227 SOUTH KOREA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 228 SOUTH KOREA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 229 SOUTH KOREA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 230 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 231 REST OF ASIA PACIFIC: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 232 REST OF ASIA PACIFIC: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 233 REST OF ASIA PACIFIC: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 234 REST OF ASIA PACIFIC: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 235 REST OF ASIA PACIFIC: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 236 REST OF ASIA PACIFIC: STABILITY TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 237 REST OF ASIA PACIFIC: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 238 LATIN AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 239 LATIN AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 240 LATIN AMERICA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 241 LATIN AMERICA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 242 LATIN AMERICA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 243 LATIN AMERICA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 244 LATIN AMERICA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 245 LATIN AMERICA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 246 LATIN AMERICA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 247 LATIN AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 248 BRAZIL: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 249 BRAZIL: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 250 BRAZIL: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 251 BRAZIL: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 252 BRAZIL: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 253 BRAZIL: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 254 BRAZIL: STABILITY TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 255 BRAZIL: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 256 MEXICO: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 257 MEXICO: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 258 MEXICO: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 259 MEXICO: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 260 MEXICO: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 261 MEXICO: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 262 MEXICO: STABILITY TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 263 MEXICO: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 264 REST OF LATIN AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 265 REST OF LATIN AMERICA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 266 REST OF LATIN AMERICA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 267 REST OF LATIN AMERICA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 268 REST OF LATIN AMERICA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 269 REST OF LATIN AMERICA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 270 REST OF LATIN AMERICA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 271 REST OF LATIN AMERICA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 272 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 273 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 274 MIDDLE EAST & AFRICA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 275 MIDDLE EAST & AFRICA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 276 MIDDLE EAST & AFRICA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 277 MIDDLE EAST & AFRICA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 278 MIDDLE EAST & AFRICA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 279 MIDDLE EAST & AFRICA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 280 MIDDLE EAST & AFRICA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 281 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 282 GCC: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 283 GCC: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 284 GCC: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 285 GCC: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 286 GCC: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 287 GCC: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 288 GCC: STABILITY TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 289 GCC: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 290 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 291 REST OF MIDDLE EAST & AFRICA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 292 REST OF MIDDLE EAST & AFRICA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 293 REST OF MIDDLE EAST & AFRICA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 294 REST OF MIDDLE EAST & AFRICA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 295 REST OF MIDDLE EAST & AFRICA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 296 REST OF MIDDLE EAST & AFRICA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 297 REST OF MIDDLE EAST & AFRICA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 298 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: DEGREE OF COMPETITION
  • TABLE 299 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: SERVICE FOOTPRINT
  • TABLE 300 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: END-USER FOOTPRINT
  • TABLE 301 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: REGIONAL FOOTPRINT
  • TABLE 302 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: DETAILED LIST OF KEY START-UPS/SMES
  • TABLE 303 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: COMPETITIVE BENCHMARKING OF START-UPS/SMES
  • TABLE 304 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: SERVICE LAUNCHES, JANUARY 2020–MARCH 2024
  • TABLE 305 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: DEALS, JANUARY 2020–MARCH 2024
  • TABLE 306 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: EXPANSIONS, JANUARY 2020–MARCH 2024
  • TABLE 307 EUROFINS SCIENTIFIC: COMPANY OVERVIEW
  • TABLE 308 EUROFINS SCIENTIFIC: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 309 EUROFINS SCIENTIFIC: DEALS
  • TABLE 310 LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY OVERVIEW
  • TABLE 311 LABORATORY CORPORATION OF AMERICA HOLDINGS: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 312 LABORATORY CORPORATION OF AMERICA HOLDINGS: DEALS
  • TABLE 313 LABORATORY CORPORATION OF AMERICA HOLDINGS: EXPANSIONS
  • TABLE 314 WUXI APPTEC: COMPANY OVERVIEW
  • TABLE 315 WUXI APPTEC: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 316 WUXI APPTEC: SERVICE LAUNCHES
  • TABLE 317 WUXI APPTEC: DEALS
  • TABLE 318 WUXI APPTEC: EXPANSIONS
  • TABLE 319 CHARLES RIVER LABORATORIES: COMPANY OVERVIEW
  • TABLE 320 CHARLES RIVER LABORATORIES: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 321 CHARLES RIVER LABORATORIES: SERVICE LAUNCHES
  • TABLE 322 CHARLES RIVER LABORATORIES: DEALS
  • TABLE 323 SGS S.A.: COMPANY OVERVIEW
  • TABLE 324 SGS S.A.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 325 SGS S.A.: DEALS
  • TABLE 326 SGS S.A.: OTHER DEVELOPMENTS
  • TABLE 327 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
  • TABLE 328 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 329 THERMO FISHER SCIENTIFIC INC.: DEALS
  • TABLE 330 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS
  • TABLE 331 MEDPACE, INC.: COMPANY OVERVIEW
  • TABLE 332 MEDPACE, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 333 SARTORIUS AG: COMPANY OVERVIEW
  • TABLE 334 SARTORIUS AG: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 335 SARTORIUS AG: DEALS
  • TABLE 336 INTERTEK GROUP PLC: COMPANY OVERVIEW
  • TABLE 337 INTERTEK GROUP PLC: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 338 INTERTEK GROUP PLC: DEALS
  • TABLE 339 INTERTEK GROUP PLC: EXPANSIONS
  • TABLE 340 MERCK KGAA: COMPANY OVERVIEW
  • TABLE 341 MERCK KGAA: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 342 MERCK KGAA: SERVICE LAUNCHES
  • TABLE 343 MERCK KGAA: DEALS
  • TABLE 344 MERCK KGAA: EXPANSIONS
  • TABLE 345 MERCK KGAA: OTHER DEVELOPMENTS
  • TABLE 346 SOURCE BIOSCIENCE: COMPANY OVERVIEW
  • TABLE 347 SOURCE BIOSCIENCE: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 348 SOURCE BIOSCIENCE: SERVICE LAUNCHES
  • TABLE 349 SOURCE BIOSCIENCE: EXPANSIONS
  • TABLE 350 ICON PLC: COMPANY OVERVIEW
  • TABLE 351 ICON PLC: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 352 ICON PLC: DEALS
  • TABLE 353 ALS: COMPANY OVERVIEW
  • TABLE 354 ALS: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 355 ALS: DEALS
  • TABLE 356 FRONTAGE LABORATORIES, INC.: COMPANY OVERVIEW
  • TABLE 357 FRONTAGE LABORATORIES, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 358 FRONTAGE LABORATORIES, INC.: DEALS
  • TABLE 359 FRONTAGE LABORATORIES, INC.: OTHER DEVELOPMENTS
  • TABLE 360 STERIS: COMPANY OVERVIEW
  • TABLE 361 STERIS: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 362 IQVIA INC.: COMPANY OVERVIEW
  • TABLE 363 IQVIA INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 364 IQVIA INC.: OTHER DEVELOPMENTS
  • TABLE 365 ELEMENT MATERIALS TECHNOLOGY: COMPANY OVERVIEW
  • TABLE 366 ELEMENT MATERIALS TECHNOLOGY: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 367 ELEMENT MATERIALS TECHNOLOGY: SERVICE LAUNCHES
  • TABLE 368 ELEMENT MATERIALS TECHNOLOGY: DEALS
  • TABLE 369 ELEMENT MATERIALS TECHNOLOGY: EXPANSIONS
  • TABLE 370 PACE ANALYTICAL SERVICES: COMPANY OVERVIEW
  • TABLE 371 PACE ANALYTICAL SERVICES: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 372 PACE ANALYTICAL SERVICES: DEALS
  • TABLE 373 PACE ANALYTICAL SERVICES: OTHER DEVELOPMENTS
  • TABLE 374 ALMAC GROUP: COMPANY OVERVIEW
  • TABLE 375 ALMAC GROUP: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 376 ALMAC GROUP: SERVICE LAUNCHES
  • TABLE 377 ALMAC GROUP: EXPANSIONS
  • TABLE 378 PHARMARON: COMPANY OVERVIEW
  • TABLE 379 PHARMARON: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 380 PHARMARON: DEALS
  • TABLE 381 SYNEOS HEALTH: COMPANY OVERVIEW
  • TABLE 382 PAREXEL INTERNATIONAL (MA) CORPORATION: COMPANY OVERVIEW
  • TABLE 383 LGC LIMITED: COMPANY OVERVIEW
  • TABLE 384 CELERION: COMPANY OVERVIEW
  • TABLE 385 BIOAGILYTIX: COMPANY OVERVIEW
LIST OF FIGURES
 
  • FIGURE 1 MARKETS COVERED
  • FIGURE 2 REGIONAL SEGMENTATION
  • FIGURE 3 RESEARCH DESIGN
  • FIGURE 4 PRIMARY SOURCES
  • FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY, DESIGNATION, AND REGION
  • FIGURE 7 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
  • FIGURE 8 REVENUE SHARE ANALYSIS: COMPANY ILLUSTRATION
  • FIGURE 9 REVENUE SHARE ANALYSIS ILLUSTRATION
  • FIGURE 10 TOP-DOWN APPROACH
  • FIGURE 11 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 12 CAGR PROJECTIONS
  • FIGURE 13 DATA TRIANGULATION METHODOLOGY
  • FIGURE 14 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 15 BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 16 PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 17 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
  • FIGURE 18 GEOGRAPHICAL SNAPSHOT OF HEALTHCARE ANALYTICAL TESTING SERVICES MARKET
  • FIGURE 19 GROWING ADOPTION OF OUTSOURCED ANALYTICAL TESTING SERVICES BY PHARMACEUTICAL AND MEDICAL DEVICE COMPANIES TO DRIVE GROWTH
  • FIGURE 20 BIOANALYTICAL TESTING SERVICES SEGMENT ACCOUNTED FOR LARGEST SHARE IN 2023
  • FIGURE 21 CHINA, INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
  • FIGURE 22 APAC TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD (2022–2029)
  • FIGURE 23 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
  • FIGURE 24 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 25 INCREASING NUMBER OF CLINICAL TRIALS WORLDWIDE (2004–2024)
  • FIGURE 26 PERCENTAGE OF REGISTERED STUDIES BY LOCATION (AS OF MARCH 08, 2024)
  • FIGURE 27 PHARMACEUTICAL & BIOPHARMACEUTICAL R&D EXPENDITURE, 2002–2022
  • FIGURE 28 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 29 VALUE CHAIN ANALYSIS
  • FIGURE 30 PORTER’S FIVE FORCES ANALYSIS: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET
  • FIGURE 31 REVENUE SHIFT AND NEW POCKETS: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET
  • FIGURE 32 NUMBER OF INVESTOR DEALS IN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY KEY PLAYER, 2018–2022
  • FIGURE 33 VALUE OF INVESTOR DEALS IN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY KEY PLAYER, 2018-2022
  • FIGURE 34 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS
  • FIGURE 35 KEY BUYING CRITERIA FOR END USERS
  • FIGURE 36 R&D SPENDING OF PHARMA MEMBER COMPANIES, 2020–2022
  • FIGURE 37 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: GEOGRAPHIC SNAPSHOT
  • FIGURE 38 NORTH AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET
  • FIGURE 39 US: PIPELINE SPLIT OF PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY PHASE (JANUARY 2021)
  • FIGURE 40 CANADA: ONGOING CLINICAL TRIALS, BY THERAPEUTIC AREA (2023)
  • FIGURE 41 ASIA PACIFIC: HEALTHCARE ANALYTICS TESTING SERVICES MARKET SNAPSHOT
  • FIGURE 42 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: STRATEGIES ADOPTED
  • FIGURE 43 REVENUE ANALYSIS FOR KEY PLAYERS (2018–2022)
  • FIGURE 44 MARKET SHARE ANALYSIS OF KEY PLAYERS (2022)
  • FIGURE 45 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 46 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: OVERALL FOOTPRINT
  • FIGURE 47 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: COMPANY EVALUATION MATRIX (START-UPS/SMES), 2023
  • FIGURE 48 EV/EBITDA OF KEY VENDORS
  • FIGURE 49 BRAND/PRODUCT COMPARATIVE ANALYSIS OF KEY PLAYERS, BY SERVICE TYPE
  • FIGURE 50 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2022)
  • FIGURE 51 LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY SNAPSHOT (2022)
  • FIGURE 52 WUXI APPTEC: COMPANY SNAPSHOT (2022)
  • FIGURE 53 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2022)
  • FIGURE 54 SGS S.A.: COMPANY SNAPSHOT (2023)
  • FIGURE 55 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2022)
  • FIGURE 56 MEDPACE, INC.: COMPANY SNAPSHOT (2022)
  • FIGURE 57 SARTORIUS AG: COMPANY SNAPSHOT (2022)
  • FIGURE 58 INTERTEK GROUP PLC: COMPANY SNAPSHOT (2022)
  • FIGURE 59 MERCK KGAA: COMPANY SNAPSHOT (2022)
  • FIGURE 60 SOURCE BIOSCIENCE: COMPANY SNAPSHOT (2022)
  • FIGURE 61 ICON PLC: COMPANY SNAPSHOT (2022)
  • FIGURE 62 ALS: COMPANY SNAPSHOT (2022)
  • FIGURE 63 FRONTAGE LABORATORIES, INC.: COMPANY SNAPSHOT (2022)
  • FIGURE 64 STERIS: COMPANY SNAPSHOT (2023)
  • FIGURE 65 IQVIA INC.: COMPANY SNAPSHOT (2023)

This research study involved the extensive use of both primary and secondary sources. It involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, the competitive landscape of market players, and key market dynamics such as drivers, opportunities, challenges, restraints, and key player strategies.

Secondary Research

This research study involved the wide use of secondary sources, directories, databases such as Dun & Bradstreet, Bloomberg Businessweek, and Factiva, white papers, and companies’ house documents. Secondary research was undertaken to identify and collect information for this extensive, technical, market-oriented, and commercial study of the Analytical Testing Services Market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various supply side and demand side sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side included industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, engineers, and related key executives from various companies and organizations operating in the Analytical Testing Services Market. Primary sources from the demand side included researchers, lab technicians, reagent suppliers, purchase managers etc,  and stakeholders in corporate & government bodies.

A breakdown of the primary respondents is provided below:

Healthcare Analytical Testing Services Market Size, and Share

*Others include sales managers, marketing managers, and product managers.

Note: Tiers are defined based on a company’s total revenue, as of 2020: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The total size of the Analytical Testing Services Market was arrived at after data triangulation through the two approaches mentioned below. After the completion of each approach, the weighted average of these approaches was taken based on the level of assumptions used in each approach.

Healthcare Analytical Testing Services Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Data Triangulation

The size of the Analytical Testing Service Market was estimated through segmental extrapolation using the bottom-up approach. The methodology used is as given below:

  • Shares of leading players in the Analytical Testing Services Market were gathered from secondary sources to the extent available. In some instances, shares of Analytical Testing Services have been ascertained after a detailed analysis of various parameters, including Service portfolios, market positioning, selling price, and geographic reach & strength.
  • Individual shares or revenue estimates were validated through interviews with experts.

The total revenue in the Analytical Testing Services Market was determined by extrapolating the Market share data of major companies.

Global Analytical Testing Services Market  Size: Top-Down Approach

Healthcare Analytical Testing Services Market Size, and Share

Market Definition

Healthcare analytical testing services are specifically utilized by the healthcare industry, particularly, pharmaceutical, biopharmaceutical, and medical device companies, to streamline the various stages of drug discovery and development as well as the medical device testing process.

Key Stakeholders

  • Healthcare Analytical Testing Service Providers
  • Pharmaceutical & Biopharmaceutical Companies
  • Biotechnology Companies
  • Bioanalytical Testing Service Providers
  • Environmental Testing Service Providers
  • Contract Research Organizations (CROs)
  • Medical Device Manufacturing Companies
  • Cosmetic Companies
  • Nutraceutical Companies
  • Forensic Laboratories
  • Academic Universities
  • Research Institutes
  • Research Laboratories
  • Government Associations
  • Market Research And Consulting Firms
  • Venture Capitalists And Investors

Objectives of the Study

  • To define, describe, and forecast the healthcare analytical testing services market based on type, end user, and region
  • To provide detailed information about the major factors influencing the market growth (such as drivers, restraints, challenges, and opportunities)
  • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall healthcare analytical testing services market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the healthcare analytical testing services market in North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
  • To profile the key players and comprehensively analyze their market shares and core competencies in the healthcare analytical testing services market
  • To track and analyze competitive developments such as partnerships, expansions, acquisitions, collaborations, service launches, agreements, and other developments in the healthcare analytical testing services market
  • To benchmark players within the healthcare analytical testing services market using the Company Evaluation Quadrant framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and service offerings

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to 5)

Geographic Analysis

  • Further breakdown of the Rest of Europe Analytical Testing Services Market  into Denmark, Norway, and others
  • Further breakdown of the Rest of Asia Pacific Analytical Testing Services Market  into Vietnam, New Zealand, and others

Previous Versions of this Report

Healthcare Analytical Testing Services Market by Type (Biomarker Testing, Stability Testing, Raw Material Testing, Batch-release Testing, Cleaning Validation, End User (Pharmaceutical Companies, Medical Device Companies, CRO) - Global Forecast to 2027

Report Code AST 4341
Published in Dec, 2022, By MarketsandMarkets™

Healthcare Analytical Testing Services Market by Type (Method Development & Validation, Cell-based Assays, Stability Testing, Heavy Metal Testing, Thermal Analysis, Cleaning Validation), End User (Pharmaceutical Companies, CROs) - Global Forecast to 2026

Report Code AST 4341
Published in Sep, 2021, By MarketsandMarkets™

Healthcare Analytical Testing Services Market by Type (Method Development & Validation, Cell-Based Assays, Stability Testing, Heavy Metal Testing, Image Analysis, Virology Testing) & End user (Pharmaceuticals, Medical Devices) - Global Forecast to 2025

Report Code AST 4341
Published in Apr, 2020, By MarketsandMarkets™

Healthcare Analytical Testing Services Market by Type (Method Validation, Environmental Monitoring, Bioanalytical Services, Stability, Raw Materials, & Microbial Testing), End User (Pharmaceutical, Medical Device Companies, CRO) - Global Forecast to 2023

Report Code AST 4341
Published in Mar, 2018, By MarketsandMarkets™

Healthcare Analytical Testing Services Market by Type (Stability, Raw Materials, Method Validation, Microbial, Environmental Monitoring, Bioanalytical Services), by End User (Pharmaceutical Companies, Medical Device Companies) - Global Forecast to 2021

Report Code AST 4341
Published in May, 2016, By MarketsandMarkets™
"Our USP is "providing game-changing business opportunities reports with free customization" - so please feel free to provide us with your specific areas of interest / business challenges in much greater detail !!"

We appreciate your interest in this report. Once you fill out the form, you'll be immediately directed to an exclusive solution tailored to your needs. This high-value offering can help boost your revenue by 30% - a must-see opportunity for anyone looking to maximize growth.


By clicking the "Submit" button, you are agreeing to the Terms of Use and Privacy Policy.

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Healthcare Analytical Testing Services Market

DMCA.com Protection Status